THE IMPACT OF A MEDITATION-BASED STRESS REDUCTION PROGRAM ON FIBROMYALGIA

被引:211
作者
KAPLAN, KH
GOLDENBERG, DL
GALVINNADEAU, M
机构
[1] NEWTON WELLESLEY HOSP,CTR ARTHRIT FIBROMYALGIA,WELLESLEY,MA
[2] BOSTON UNIV,SCH MED,BOSTON,MA 02118
[3] TUFTS UNIV,SCH MED,BOSTON,MA 02111
关键词
D O I
10.1016/0163-8343(93)90020-O
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Fibromyalgia is a chronic illness characterized by widespread pain, fatigue, sleep disturbance, and resistance to treatment. The purpose of this study was to evaluate the effectiveness of a meditation-based stress reduction program on fibromyalgia. Seventy-seven patients meeting the 1990 criteria of the American College of Rheumatology for fibromyalgia took part in a 10-week group outpatient program. Therapists followed a carefully defined treatment approach and met weekly to further promote uniformity. Patients were evaluated before and after the program. Initial evaluation included a psychiatric structured clinical interview (SCID). Outcome measures included visual analog scales to measure global well-being, pain, sleep, fatigue, and feeling refreshed in the morning. Patients also completed a medical symptom checklist, SCL-90-R, Coping Strategies Questionnaire, Fibromyalgia Impact Questionnaire, and the Fibromyalgia Attitude Index. Although the mean scores of all the patients completing the program showed improvement, 51% showed moderate to marked improvement and only they were counted as ''responders.'' These preliminary findings suggest that a meditation-based stress reduction program is effective for patients with fibromyalgia.
引用
收藏
页码:284 / 289
页数:6
相关论文
共 39 条
[31]  
NICASSIO PM, 1985, J RHEUMATOL, V12, P462
[32]   MEDICAL-CARE UTILIZATION AND THE TRANSCENDENTAL-MEDITATION PROGRAM [J].
ORMEJOHNSON, D .
PSYCHOSOMATIC MEDICINE, 1987, 49 (05) :493-507
[33]   THE USE OF COPING STRATEGIES IN CHRONIC LOW-BACK-PAIN PATIENTS - RELATIONSHIP TO PATIENT CHARACTERISTICS AND CURRENT ADJUSTMENT [J].
ROSENSTIEL, AK ;
KEEFE, FJ .
PAIN, 1983, 17 (01) :33-44
[34]   TREATMENT OF PRIMARY FIBROSITIS FIBROMYALGIA SYNDROME WITH IBUPROFEN AND ALPRAZOLAM - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
RUSSELL, IJ ;
FLETCHER, EM ;
MICHALEK, JE ;
MCBROOM, PC ;
HESTER, GG .
ARTHRITIS AND RHEUMATISM, 1991, 34 (05) :552-560
[36]  
SPITZER RL, 1987, STRUCTURED CLIN INTE
[37]   THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY 1990 CRITERIA FOR THE CLASSIFICATION OF FIBROMYALGIA - REPORT OF THE MULTICENTER CRITERIA COMMITTEE [J].
WOLFE, F ;
SMYTHE, HA ;
YUNUS, MB ;
BENNETT, RM ;
BOMBARDIER, C ;
GOLDENBERG, DL ;
TUGWELL, P ;
CAMPBELL, SM ;
ABELES, M ;
CLARK, P ;
FAM, AG ;
FARBER, SJ ;
FIECHTNER, JJ ;
FRANKLIN, CM ;
GATTER, RA ;
HAMATY, D ;
LESSARD, J ;
LICHTBROUN, AS ;
MASI, AT ;
MCCAIN, GA ;
REYNOLDS, WJ ;
ROMANO, TJ ;
RUSSELL, IJ ;
SHEON, RP .
ARTHRITIS AND RHEUMATISM, 1990, 33 (02) :160-172
[38]  
WOLFE F, 1988, J RHEUMATOL, V15, P1047
[39]  
Yalom ID, 1970, THEORY PRACTICE GROU